✦ LIBER ✦

To restrict indication for stenting of the inferior vena cava and liver transplantation in patients with Budd-Chiari syndrome

✍ Scribed by Wang, Zhonggao

Book ID: 107472128
Publisher: Higher Education Press and Springer
Year: 2007
Tongue: English
Weight: 475 KB
Volume: 1
Category: Article
ISSN: 1673-7342
DOI: 10.1007/s11684-007-0025-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budd?Chiari syndrome due to membranous o

Budd?Chiari syndrome due to membranous obstruction of inferior vena cava in a patient with Behcet's disease

✍ EBRAHIMI, Mahmood ;JOKAR, Mohammadhassan ;TAHERI, Reza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

TIPS Can Be Lifesaving in Acute Liver Fa

TIPS Can Be Lifesaving in Acute Liver Failure Associated with Portal Vein and Inferior Vena Cava Thrombosis in a Case of Budd Chiari Syndrome Due to Protein S Deficiency

✍ Ashish Verma; Gagan Sharma; Suyash Mohan; Vivek A. Saraswat; Sanjay S. Baijal 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 148 KB

Treatment of Superior Vena Cava (SVC) Sy

Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation

✍ Alexander Sauter; Jürgen Triller; Felix Schmidt; Ralph Kickuth 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 189 KB

Can the model for end-stage liver diseas

Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?

✍ Sarwa Darwish Murad; W. Ray Kim; Piet C. de Groen; Patrick S. Kamath; Michael Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

The model for end-stage liver disease (MELD) is a widely accepted and objective scoring system for end-stage liver disease (ESLD) but has never been evaluated for Budd-Chiari syndrome (BCS). We investigated whether MELD can be used to predict survival in patients with BCS. Patients with BCS (n ϭ 237